ECA
ZBH icon

Elevated Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Elevated Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344 Hold
4
– – ﹤0.01% 816
2026
Q1 		$362 Hold
4
– – ﹤0.01% 805
2025
Q4 		$360 Buy
+4
New +$379 ﹤0.01% 789

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Elevated Capital Advisors's ZBH Position: Q2 2026 in Review

Elevated Capital Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 4 shares worth $344. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Elevated Capital Advisors first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $362 in Q1 2026. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Elevated Capital Advisors held 4 shares of Zimmer Biomet worth $344 as of Q2 2026.
  • Elevated Capital Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #816 holding.
  • Elevated Capital Advisors first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Zimmer Biomet position peaked at $362 in Q1 2026.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.